Germline variants in CDKN2A wild-type melanoma prone families.

IF 6.6 2区 医学 Q1 Biochemistry, Genetics and Molecular Biology
Molecular Oncology Pub Date : 2025-05-01 Epub Date: 2025-03-12 DOI:10.1002/1878-0261.70020
Gjertrud T Iversen, Marie Loeng, Amalie Lund Holth, Per E Lønning, Jürgen Geisler, Stian Knappskog
{"title":"Germline variants in CDKN2A wild-type melanoma prone families.","authors":"Gjertrud T Iversen, Marie Loeng, Amalie Lund Holth, Per E Lønning, Jürgen Geisler, Stian Knappskog","doi":"10.1002/1878-0261.70020","DOIUrl":null,"url":null,"abstract":"<p><p>Germline pathogenic variants in CDKN2A are well established as an underlying cause of familial malignant melanoma. While pathogenic variants in other genes have also been linked to melanoma, most familial cases remain unexplained. We assessed pathogenic germline variants in 360 cancer-related genes in 56 Norwegian melanoma-prone families. The index cases were selected based on familial history of melanoma and/or multiple primary melanomas, along with previous negative tests for pathogenic CDKN2A variants. We found 6 out of 56 index individuals to carry germline pathogenic or likely pathogenic variants in BRCA2, MRE11, ATM, MSH2, CHEK2, and AR. One family member with melanoma (not index case) carried a pathogenic variant in MAP3K6. In addition, we found a high fraction of variants previously considered benign and/or as variants of uncertain significance in xeroderma pigmentosum-related genes. In particular, XPC<sup>L48F</sup> was found in 8 indexes; thus, the allele fraction (0.07) was significantly higher than in comparable healthy populations (0.02-0.03; P-values from 0.007 to 0.014). In conclusion, we found that several melanoma-prone families have pathogenic variants in genes not usually linked to melanoma.</p>","PeriodicalId":18764,"journal":{"name":"Molecular Oncology","volume":" ","pages":"1493-1507"},"PeriodicalIF":6.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077288/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/1878-0261.70020","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/12 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Germline pathogenic variants in CDKN2A are well established as an underlying cause of familial malignant melanoma. While pathogenic variants in other genes have also been linked to melanoma, most familial cases remain unexplained. We assessed pathogenic germline variants in 360 cancer-related genes in 56 Norwegian melanoma-prone families. The index cases were selected based on familial history of melanoma and/or multiple primary melanomas, along with previous negative tests for pathogenic CDKN2A variants. We found 6 out of 56 index individuals to carry germline pathogenic or likely pathogenic variants in BRCA2, MRE11, ATM, MSH2, CHEK2, and AR. One family member with melanoma (not index case) carried a pathogenic variant in MAP3K6. In addition, we found a high fraction of variants previously considered benign and/or as variants of uncertain significance in xeroderma pigmentosum-related genes. In particular, XPCL48F was found in 8 indexes; thus, the allele fraction (0.07) was significantly higher than in comparable healthy populations (0.02-0.03; P-values from 0.007 to 0.014). In conclusion, we found that several melanoma-prone families have pathogenic variants in genes not usually linked to melanoma.

CDKN2A野生型黑色素瘤易发家族的种系变异
CDKN2A的种系致病变异已被确定为家族性恶性黑色素瘤的潜在原因。虽然其他基因的致病变异也与黑色素瘤有关,但大多数家族性病例仍无法解释。我们评估了56个挪威黑色素瘤易发家族中360个癌症相关基因的致病种系变异。指标病例的选择是基于黑色素瘤和/或多发性原发性黑色素瘤的家族史,以及之前致病性CDKN2A变异的阴性检测。我们发现56个指标个体中有6个携带BRCA2、MRE11、ATM、MSH2、CHEK2和AR的种系致病性或可能致病性变异。一个黑色素瘤家族成员(非指标病例)携带MAP3K6的致病性变异。此外,我们发现在色素干皮病相关基因中,以前被认为是良性和/或不确定意义的变异的很大一部分。其中,XPCL48F出现在8个指标中;因此,等位基因分数(0.07)显著高于可比健康人群(0.02-0.03;p值从0.007到0.014)。总之,我们发现几个易患黑色素瘤的家族在通常与黑色素瘤无关的基因中具有致病性变异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular Oncology
Molecular Oncology Biochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
11.80
自引率
1.50%
发文量
203
审稿时长
10 weeks
期刊介绍: Molecular Oncology highlights new discoveries, approaches, and technical developments, in basic, clinical and discovery-driven translational cancer research. It publishes research articles, reviews (by invitation only), and timely science policy articles. The journal is now fully Open Access with all articles published over the past 10 years freely available.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信